InterOcean Capital Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$319K Buy
616
+3
+0.5% +$1.49K 0.01% 381
2023
Q4
$289K Hold
613
0.01% 374
2023
Q3
$267K Sell
613
-9
-1% -$4.08K 0.01% 369
2023
Q2
$276K Sell
622
-21
-3% -$9.69K 0.01% 368
2023
Q1
$296K Sell
643
-24
-4% -$11.4K 0.01% 323
2022
Q4
$342K Buy
667
+16
+2% +$8.12K 0.01% 309
2022
Q3
$296K Hold
651
0.01% 308
2022
Q2
$314K Buy
+651
New +$322K 0.01% 321

Other funds holding ELV

InterOcean Capital Group's ELV Position: Q1 2024 in Review

InterOcean Capital Group increased its Elevance Health (ELV) stake by 0.49% in Q1 2024, buying an estimated $1.49K and bringing the position to 616 shares worth $319K. The position accounts for 0.01% of the portfolio, ranked #381.

InterOcean Capital Group first reported a position in ELV in Q2 2022 and has held it in 8 quarters since. The position peaked at $342K in Q4 2022. 1,667 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • InterOcean Capital Group held 616 shares of Elevance Health worth $319K as of Q1 2024.
  • InterOcean Capital Group bought 3 Elevance Health shares in Q1 2024, an estimated $1.49K.
  • Elevance Health made up 0.01% of InterOcean Capital Group's portfolio in Q1 2024, its #381 holding.
  • InterOcean Capital Group first reported a position in Elevance Health in Q2 2022 and has held it in 8 quarters since.
  • InterOcean Capital Group's Elevance Health position peaked at $342K in Q4 2022.
  • 1,667 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.